Pregled bibliografske jedinice broj: 434490
The assessment of genotoxicity of a newly synthesized atropine-4-oxime on human lymphocytes in vitro
The assessment of genotoxicity of a newly synthesized atropine-4-oxime on human lymphocytes in vitro // 7th Congress of the Toxicology in Developing Countries, Sun City, Južnoafrička Republika, Knjiga sažetaka
Sun City, Južnoafrička Republika, 2009. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 434490 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The assessment of genotoxicity of a newly synthesized atropine-4-oxime on human lymphocytes in vitro
Autori
Lucić Vrdoljak, Ana ; Berend, Suzana ; Kopjar, Nevenka ; Mladinić, Marin ; Želježić, Davor ; Lovrić, Jasna
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
7th Congress of the Toxicology in Developing Countries, Sun City, Južnoafrička Republika, Knjiga sažetaka
/ - , 2009
Skup
7th Congress of the Toxicology in Developing Countries (7CTDC ; 2009)
Mjesto i datum
Sun City, Južnoafrička Republika, 06.09.2009. - 10.09.2009
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
atropine-4-oxime; genotoxicity; human lymphocytes
Sažetak
Present study aimed at the evaluation of genotoxicity of a newly synthesized substance with intriguing molecular structure in which an atropine part is coupled with oxime. Both atropine and oxime have important role in the management of acute cholinergic syndrome and are involved in the recovery of inhibited enzyme acetylcholinesterase (AChE). Preliminary studies on mice indicated that LD50 of the substance equals to 10 mg/kg. Here we evaluated the effects of doses that correspond to 5%LD50 and 1/4LD50. Study was performed on isolated human peripheral lymphocytes that were incubated in vitro for 30 min in the presence of test substance with and without metabolic activation. Lymphocyte viability, apoptosis/necrosis measurements, alkaline and neutral comet assay were performed immediately after the treatment. The results show that tested substance did not significantly impair the viability of lymphocytes. Metabolic activation slightly contributed to its toxicity only when administered at concentration of 5% LD50 and it was noticed as a non-significant increase of apoptotic cells. On the contrary, oxime applied in higher dose with metabolic activation significantly increased cell viability and decreased the incidence of necrotic cells. In the alkaline comet assay both tested concentrations evoked an increase in the tail intensity compared to negative control, but differences between samples with and without metabolic activation were not statistically significant. The results of neutral comet assay show that treatment with oxime in both tested concentrations did not significantly influence integrity of lymphocyte DNA. Taken together, the findings of this study indicate an acceptable genotoxic profile of atropine-oxime on human lymphocytes in vitro, but its activity should be further tested on other cell types and animal model to elucidate whether it is a source molecule promising for application in vivo as an efficient antidote in organophosphorus poisoning.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
022-0222148-2137 - Genotoksičnost kemijskih i fizikalnih agensa prirodnog i antropogenog podrijetla (Kašuba, Vilena, MZOS ) ( CroRIS)
022-0222148-2139 - Terapijski učinak novosintetiziranih spojeva pri otrovanju organofosfatima (Lucić Vrdoljak, Ana, MZOS ) ( CroRIS)
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb
Profili:
Davor Želježić
(autor)
Ana Lucić Vrdoljak
(autor)
Nevenka Kopjar
(autor)
Suzana Žunec
(autor)
Marin Mladinić
(autor)
Jasna Lovrić
(autor)